CME Group Inc. Class A (CME)

Over the past six months, CME Group's stock price has increased by 38.49%. The stock reached an all-time high of $290.79 on June 1, 2025. Key events include strong financial performance with record volumes, a dividend increase of 9% to $1.25 per share, insider trading activity with both purchases and sales, hedge fund activity showing increased and decreased positions, congressional stock trading with one purchase, and analyst price targets with a median target of $258.00.

Demand seasonality for CME Group's products is most evident in agricultural commodity products, with seasonal patterns related to planting, harvesting, and marketing cycles. Weather derivatives also exhibit seasonal demand. Overall market volatility can significantly impact the demand for CME Group's products as market participants use them to hedge exposure and manage risk.

CME Group, Inc. is a leading global markets company operating the world's largest and most diverse derivatives marketplace. It provides derivatives contracts, clearing services, market data, and index products, operating four primary exchanges: CME, CBOT, NYMEX, and COMEX. The company's major products include futures and options across interest rates, equity indexes, foreign exchange, energy, agricultural products, metals, cryptocurrencies, and weather and real estate derivatives. Trading is primarily facilitated through CME Globex, with additional services like CME Direct and CME Clearing.

CME Group has a significant global presence with its headquarters in Chicago, Illinois, USA, and offices in New York, Houston, and Washington D.C. Internationally, it has offices and representatives in major financial centers across Europe, Asia-Pacific, and Latin America, including London, Singapore, Hong Kong, and others. Its clientele spans over 100 countries worldwide.

CME Group has maintained a strong brand reputation, consistently ranking as one of the most valuable exchange brands globally. Its brand value increased by 5% to $2.4 billion, marking its ninth consecutive year at the top. Website traffic surged by 191.84%, indicating increased popularity. The company has a Net Promoter Score (NPS) of 27 and has received awards and recognition for its market data and innovation.

CME Group's ownership is primarily dominated by institutional investors, holding approximately 89% of the company's shares. Major institutional owners include The Vanguard Group, Inc., BlackRock, Inc., and State Street Corp. Individual investors hold approximately 10-11% of the stock, while insiders own less than 1%.